Hyliion (NYSE: HYLN) files Rule 144 notice for 220,000 share sale
Rhea-AI Filing Summary
Hyliion Holdings Corp. reported that an affiliated holder plans to sell 220,000 shares of its common stock through UBS Financial Services Inc., with an aggregate market value of $432,000, on or about 12/12/2025 on the NYSE. The filing notes that Hyliion common stock outstanding was 175,400,000 shares.
The shares to be sold were acquired on 12/12/2025 in an employee benefit transaction from Hyliion Holdings Corp., with cash listed as the form of payment. The disclosure also records that Thomas Healy sold 159,776 common shares on 11/17/2025 for gross proceeds of $265,300 during the prior three months.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for Hyliion (HYLN) disclose?
The notice states that an affiliated holder of Hyliion Holdings Corp. plans to sell 220,000 shares of Hyliion common stock, with an aggregate market value of $432,000, on or about 12/12/2025 on the NYSE.
How many Hyliion (HYLN) shares are outstanding according to the filing?
The disclosure lists 175,400,000 shares of Hyliion common stock as outstanding, providing a baseline for understanding the relative size of the planned sale.
Who is involved in the recent Hyliion (HYLN) share sales and planned sale?
The filing shows a planned sale of 220,000 common shares held by an affiliated person, and it records that Thomas Healy sold 159,776 common shares on 11/17/2025.
What were the terms of the Hyliion (HYLN) shares to be sold under this notice?
The 220,000 common shares were acquired on 12/12/2025 in an employee benefit transaction from Hyliion Holdings Corp., with the form of payment identified as cash.
What prior Hyliion (HYLN) stock sales are disclosed in the last three months?
The document reports that 159,776 Hyliion common shares were sold by Thomas Healy on 11/17/2025, generating gross proceeds of $265,300.
Which broker and exchange are associated with the planned Hyliion (HYLN) share sale?
The planned sale of 220,000 common shares is listed through UBS Financial Services Inc., with the securities to be sold on the NYSE.